Paul Manning

Paul Manning

Chairman at CANDEL THERAPEUTICS, INC.

Net worth: 266 M $ as of 2024-04-29

68 year
Health Technology
Finance
Technology Services

Profile

Paul B.
Manning
was the founder of PBM Products LLC (founded in 1997) and PBM Capital Group LLC (founded in 2010), where he holds the titles of President & Chief Executive Officer and Chairman and CEO, respectively.
Mr. Manning is also the founder of Able Laboratories, Inc. Mr. Manning's current job(s) include President & Chief Executive Officer at PBM Capital Investments LLC, Chairman at Candel Therapeutics, Inc. (since 2021), Chairman at Xalud Therapeutics, Inc., Chairman at Verrica Pharmaceuticals, Inc. (since 2017), Director at PatientsLikeMe LLC (since 2022), Director at The Foundation Fighting Blindness, Inc., Director at Foundation Fighting Blindness Clinical Research Institute, Director at PBM Pharmaceuticals, Inc., Independent Director at ArcherDX LLC (since 2015), Director at Tolerion, Inc., Director at UVA Health Foundation, Independent Director at Liquidia Corp.
(since 2020), and Member at University of Virginia Community Credit Union.
Mr. Manning's former job(s) include Chairman at Dova Pharmaceuticals, Inc. (2017-2019), Director at QIAGEN Beverly LLC, Director at Gen9, Inc., Director at Advanz Pharma Corp.
Ltd.
(2014-2015), Independent Director at Novartis Gene Therapies, Inc. (2014-2018), Independent Director at Taysha Gene Therapies, Inc. (2020-2023), Director at RareGen LLC (2018-2020), and Executive Vice President & General Manager at Perrigo Co. (2010-2014).
Mr. Manning's education history includes an undergraduate degree from the University of Massachusetts.
Mr. Manning is also the founder of Able Laboratories, Inc...

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-30 15,589,481 ( 36.75% ) 104 M $ 2024-04-29
2024-04-25 6,245,114 ( 8.21% ) 77 M $ 2024-04-29
2024-03-30 23,417,778 ( 12.52% ) 54 M $ 2024-04-29
2024-03-31 2,877,158 ( 9.80% ) 20 M $ 2024-04-29
2024-04-07 3,205,128 ( 5.33% ) 10 M $ 2024-04-29
2024-03-22 130,434 ( 12.51% ) 944 342 $ 2024-04-29

Paul Manning active positions

CompaniesPositionStart
VERRICA PHARMACEUTICALS INC. Chairman 2017-11-30
LIQUIDIA CORPORATION Director/Board Member 2020-11-17
CANDEL THERAPEUTICS, INC. Chairman 2021-07-14
Corporate Officer/Principal -
Director/Board Member 2022-01-18
Chairman -
Director/Board Member -
Director/Board Member 2014-12-31
Director/Board Member -
░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Paul Manning

Former positions of Paul Manning

CompaniesPositionEnd
░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Paul Manning's experience

Training of Paul Manning

University of Massachusetts Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Manning's experience

Connections

100 +

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
VERRICA PHARMACEUTICALS INC.

Health Technology

TAYSHA GENE THERAPIES, INC.

Health Technology

LIQUIDIA CORPORATION

Health Technology

CANDEL THERAPEUTICS, INC.

Health Technology

Private companies21

Consumer Non-Durables

Commercial Services

Health Technology

Able Laboratories, Inc.

Health Technology

Beta-Pro LLC

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Technology Services

Health Technology

Health Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Technology Services

Finance

Pbm Capital Investments LLC

See company connections